Next Article in Journal
Evaluation of Different DNA Vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) in Pigs
Next Article in Special Issue
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
Previous Article in Journal
DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
Vaccines 2013, 1(4), 444-462; doi:10.3390/vaccines1040444
Review

Chemokines as Cancer Vaccine Adjuvants

1, 2,*  and 2,*
Received: 22 July 2013; in revised form: 31 August 2013 / Accepted: 26 September 2013 / Published: 16 October 2013
(This article belongs to the Special Issue Dendritic Cell Vaccine)
View Full-Text   |   Download PDF [1109 KB, updated 17 October 2013; original version uploaded 16 October 2013]   |   Browse Figure
Abstract: We are witnessing a new era of immune-mediated cancer therapies and vaccine development. As the field of cancer vaccines advances into clinical trials, overcoming low immunogenicity is a limiting step in achieving full success of this therapeutic approach. Recent discoveries in the many biological roles of chemokines in tumor immunology allow their exploitation in enhancing recruitment of antigen presenting cells (APCs) and effector cells to appropriate anatomical sites. This knowledge, combined with advances in gene therapy and virology, allows researchers to employ chemokines as potential vaccine adjuvants. This review will focus on recent murine and human studies that use chemokines as therapeutic anti-cancer vaccine adjuvants.
Keywords: chemokines; dendritic cell; immunotherapy; cancer vaccine; adjuvant chemokines; dendritic cell; immunotherapy; cancer vaccine; adjuvant
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bobanga, I.D.; Petrosiute, A.; Huang, A.Y. Chemokines as Cancer Vaccine Adjuvants. Vaccines 2013, 1, 444-462.

AMA Style

Bobanga ID, Petrosiute A, Huang AY. Chemokines as Cancer Vaccine Adjuvants. Vaccines. 2013; 1(4):444-462.

Chicago/Turabian Style

Bobanga, Iuliana D.; Petrosiute, Agne; Huang, Alex Y. 2013. "Chemokines as Cancer Vaccine Adjuvants." Vaccines 1, no. 4: 444-462.


Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert